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University of Pennsylvania, Philadelphia, Pennsylvania 19104Received May 31, 2000; accepted June 15, 2000Herpesviruses have been classified into three subfam-
ilies on the basis of biological characteristics and
genomic analysis. Members of the alphaherpesvirus
subfamily are neurotropic, have a short replicative cycle,
and, in general, have a broad host range. In addition,
they encode a similar set of homologous genes arranged
in similar order. Also, selected proteins of one alphaher-
pesvirus may functionally substitute for the homolog of
another.
Human herpes simplex viruses 1 and 2 (HSV-1 and
HSV-2), porcine pseudorabies virus (PRV), and bovine
herpesvirus 1 (BHV-1) are representative members of the
alphaherpesvirus subfamily and are the subject of this
review. Natural diseases associated with infections by
these viruses are restricted to specific hosts. However,
these viruses can infect selected laboratory animals,
such as rodents, and all have a relatively broad host
range for cultured cells, at least for entry. The obvious
inferences are that each of these viruses can use multi-
ple cell surface receptors for entry or that each can
recognize structural features of receptors conserved
among human and animal species. The evidence sum-
marized here shows that both inferences are correct.
The usual manifestations of HSV disease are lesions
on mucosal epithelium (oral or genital), skin, or cornea;
latent infection of neurons in sensory ganglia; and per-
haps recurrent lesions at the site of primary infection,
due to reactivation of latent virus from the ganglia. En-
cephalitis can occur, albeit rarely in children or adults;
newborn infants can suffer from severe disseminated
disease. PRV and BHV-1 can cause similar manifesta-
tions of disease in pigs and cattle. Thus, important cel-
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ressed at Department of Microbiology–Immunology, Northwestern
niversity Medical School, Mail Code S213, Room Ward 6-241, 320 East
uperior Street, Chicago, IL 60611. Fax: 312-503-1339. E-mail:
-spear@northwestern.edu.
1lular targets of infection include cells of the mucosal
epithelium and neurons, but are not limited to these cell
types.
The focus of this review is cell surface receptors for
entry of alphaherpesviruses into cells. The pathway of
entry is via fusion of the virion envelope with a cell
membrane, often the cell plasma membrane. Membrane
fusion induced by alphaherpesviruses does not require
activation by low pH but depends upon multiple interac-
tions of viral proteins with cell surface components. Fig-
ure 1 identifies components of the viral envelope and cell
membrane that govern viral entry and are described
below. The information summarized here probably ap-
plies to most alphaherpesviruses except for those, such
as varicella-zoster virus, that apparently lack a gene
encoding gD, a viral glycoprotein central to the entry
process for HSV, PRV, and BHV-1. Citations listed at the
end are mostly recent publications related to cell recep-
tors for these viruses; reviews should be consulted for
earlier work.
The components of a herpesvirus particle are its DNA
core, icosahedral capsid, tegument (proteins located be-
tween the capsid surface and envelope), and envelope,
which is a lipid bilayer containing multiple viral mem-
brane proteins and glycoproteins.
The alphaherpesvirus envelope contains about a
dozen viral membrane proteins, only five of which have
defined roles in viral entry. For HSV-1, PRV, and BHV-1,
binding of virus to cells is mediated principally by gC,
although other glycoproteins such as gB and gD can
contribute to stable binding or can substitute for gC in
mediating binding. Penetration of virus requires fusion of
the virion envelope with a cell membrane and depends
on the action of gB, gD, gH, and gL. Deletion of the genes
for any one of these four glycoproteins is lethal and
results in production of virions that can bind to cells,
provided gC is present, but cannot penetrate. Interest-
ingly, deletion of gC is not a lethal mutation, although it
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2 MINIREVIEWcan cause reduced binding and infectivity [see reviews
by Mettenleiter (2000) and Spear (1993a) for citations
documenting these findings].
For PRV and BHV-1, at least, the lethal effects of de-
leting gD can be partially reversed by secondary muta-
tions that enable infectious virus to be produced in the
absence of gD (Schmidt et al., 1997; Schro¨der et al.,
1997). The secondary mutations are probably multiple
and remain to be fully defined but may include a mutation
in gH, at least in the case of BHV-1 (Schro¨der and Keil,
1999). These results suggest that gD is not necessarily
an essential part of the membrane-fusing machinery,
although it is the viral ligand for cell surface receptors
that mediate viral entry, as discussed below.
The initial interaction of HSV-1, HSV-2, PRV, and BHV-1
with cells is usually binding of virion gC to cell surface
glycosaminoglycans, preferentially heparan sulfate (Met-
tenleiter et al., 1990; Okazaki et al., 1991; Shieh et al.,
992; WuDunn and Spear, 1989). The importance of
eparan sulfate as a cell determinant of viral entry is
nderscored by the results of selecting for cell mutants
hat are resistant to the cytotoxic effects of HSV. Such
utants have been isolated from mouse L cells (Banfield
t al., 1995; Gruenheid et al., 1993) and Chinese hamster
vary (CHO) cells (Wei et al., 2000) and, in both cases,
ere defective for heparan sulfate biosynthesis and par-
ially or substantially resistant to viral entry. The ability of
lphaherpesviruses to bind to cells via interactions with
eparan sulfate is a feature of clinical isolates as well as
aboratory strains. It is not a property acquired by the
assage of virus in cultured cells (Terhune et al., 1998).
Neither gC nor heparan sulfate is absolutely required
for entry of virus into cells. In the absence of gC, all of the
alphaherpesviruses described here can infect cells, al-
FIG. 1. Molecular determinants of HSV entry into cells. Five of the
dozen or so membrane glycoproteins in the viral envelope have defined
roles in viral entry. The initial binding of virus to cell surface heparan
sulfate (HS) can be mediated by viral gC or gB. This facilitates the
binding of gD to any one of several cell surface receptors. These
include HVEM, a member of the TNF receptor family, nectin-1 or
nectin-2, both members of the immunoglobulin superfamily, or specific
sites in heparan sulfate (3-O-S) generated by the action of specific
3-O-sulfotransferases. The binding of gD to one of these receptors can
then trigger fusion between the virion envelope and cell membrane.
This fusion requires the concerted action of gB, gD, gH, and gL. Other
alphaherpesviruses express related glycoproteins with similar roles in
entry and can also use nectins as gD receptors for entry.though the efficiency of binding and entry may be se-
verely reduced (Herold et al., 1991; Mettenleiter, 1989;
n
nOkazaki et al., 1987). In the case of HSV, gB can mediate
the binding of virus to heparan sulfate if gC is absent
(Herold et al., 1994). In the case of PRV and BHV-1, it is
not known how gC-negative mutants bind to cells but the
binding appears not to be dependent on heparan sulfate
(Karger et al., 1995; Klupp et al., 1997). In the absence of
heparan sulfate and other glycosoaminoglycans to
which virus can bind, entry is very inefficient but can
occur, probably through the interaction of gD with cell
surface receptors.
Binding of virus to heparan sulfate does not necessar-
ily lead to alphaherpesvirus entry. HSV-1, PRV, and BHV-1
can bind to heparan sulfate on certain cell types, such as
CHO cells, but fail to penetrate (Geraghty et al., 1998;
Shieh et al., 1992). The existence of cells that allowed
virus binding, but resisted entry, facilitated the expres-
sion cloning of cDNAs encoding human and mouse
proteins capable of converting resistant cells to suscep-
tibility to HSV entry. Heparan sulfate and the new recep-
tors identified by expression cloning will be referred to
as coreceptors for entry because, in general, alphaher-
pesvirus entry is facilitated by, if not dependent on, in-
teractions of viral proteins with at least two, perhaps
more, cell surface receptors.
Table 1 lists the human and rodent proteins shown to
serve as coreceptors, or to generate coreceptors, for the
entry of HSV and other alphaherpesviruses. The first HSV
entry receptor to be identified was a previously unrec-
ognized human member of the tumor necrosis factor
(TNF) receptor family, designated herpesvirus entry me-
diator (HVEM) originally (Montgomery et al., 1996) and
later herpesvirus entry protein A (HveA) (Warner et al.,
1998) and catalogued as TNFRSF14. Additional human
entry receptors were identified (Cocchi et al., 1998; Ger-
aghty et al., 1998; Warner et al., 1998) and proved to be
related members of the immunoglobulin superfamily, a
subfamily including the poliovirus receptor (CD155)
(Mendelsohn et al., 1989) and two proteins that are not
receptors for poliovirus but were originally designated
poliovirus receptor-related protein-1 (Prr1) (Lopez et al.,
1995) and poliovirus receptor-related protein 2 (Prr2)
(Eberle´ et al., 1995) and were renamed HveC (Geraghty
et al., 1998) and HveB (Warner et al., 1998), respectively.
Recently both HveB and HveC were shown to be ho-
mophilic cell adhesion molecules that localize to sites of
cadherin-based cell junctions (Aoki et al., 1997; Lopez et
al., 1998; Satoh-Horikawa et al., 2000; Takahashi et al.,
1999) and were renamed nectin-2 (HveB) and nectin-1
(HveC). CD155 and the nectins are expressed as multiple
isoforms differing at their C-termini (i.e., nectin-1a and
nectin-1b). Alphaherpesvirus entry activity is not influ-
nced by these differences provided the protein is mem-
rane-bound. Nomenclature for these viral entry recep-
ors is in a state of flux. Here we have chosen to use the
ame HVEM, rather than HveA, because the former
ame is more widely used in the literature, and to use
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3MINIREVIEWnectin-1 and nectin-2, rather than HveC and HveB, be-
cause the former names are based on cellular function.
A newly discovered HSV-1 entry receptor is generated
in heparan sulfate by the action of specific glucosaminyl
3-O-sulfotransferases. In the absence of other entry re-
ceptors described above, resistant cells can be made
susceptible to HSV-1 entry, but not entry of HSV-2, PRV, or
BHV-1, by expression of 3-O-sulfotransferase-3, provided
cell surface heparan sulfate is present (Shukla et al.,
999a).
Several remarkable findings about these coreceptors
hould be emphasized. First, at least three classes of
ell surface molecules can independently serve as co-
eceptors, along with sites recognized by gC in heparan
ulfate, for HSV entry. Second, human and mouse
Menotti et al., 2000; Shukla et al., 1999b, 2000) versions
f these proteins have similar, but not identical, entry
ctivities for the alphaherpesviruses listed in Table 1.
hird, available evidence indicates that all are receptors
or viral gD (Cocchi et al., 1998; Geraghty et al., 2000;
rummenacher et al., 1998; Nicola et al., 1998; Whitbeck
t al., 1997), except for the 3-O-sulfotransferases (3-OST-
s) that generate gD receptors in heparan sulfate
T
Human and Rodent Proteins That Serve as gD Recep
Entry mediator
Protein family
Name used
here Other names
TNF receptor HVEM ATAR; TR2; HveA;
TNFRSF-14
Related subfamily of the Nectin-1a Prr1a; HveC
immunoglobulin
superfamily
Nectin-1b Prr1b; HlgR
Nectin-2a Prr2a; HveB; Mpha
Nectin-2d Prr2d; Mphb
CD155 Pvr; Tage4c
ulfotransferase 3-OST-3A;
3-OST-3B
a Mutants of HSV-1 that are resistant to interference mediated by wil
f gD.
b For various human (Hu), mouse (Mu), or rat (Ra) orthologs of the p
entry activity and is positive or not for each virus; “NT” means “not tes
c Rat and mouse proteins named Tage4 are proposed to be the r
Lustenberger, R. J. Geraghty, P. G. Spear, and M. G. Denis, manuscripShukla et al., 1999a). Fourth, the affinities of these di-
erse receptors for gD appear to be similar with KDvalues in the micromolar range, at least for the cases of
HSV gD binding to HVEM, nectin-1, and 3-OST-3-modified
heparan sulfate (Krummenacher et al., 1999; Rux et al.,
998; Shukla et al., 1999a; Willis et al., 1998). Fifth, be-
ause sites in heparan sulfate recognized by gC are
resent on many cell types whereas the gD receptors
ave a more restricted distribution, the presence of ap-
ropriate gD receptors appears to govern the suscepti-
ility of cells to alphaherpesvirus entry. Sixth, single
mino acid substitutions in gD can result in loss of ability
o use one receptor and acquisition of ability to use
nother. For example, wild-type HSV-1 strains can enter
ells via HVEM, but not human nectin-2, whereas Rid
utants, which differ from the wild type by an amino acid
ubstitution at position 25 or 27 in gD, can use human
ectin-2 but not human HVEM (Table 1 and Fig. 2) (Lopez
t al., 2000; Warner et al., 1998). Seventh, some of the gD
receptors, such as human or mouse nectin-1 (Geraghty
et al., 1998; Menotti et al., 2000; Shukla et al., 2000), can
serve as entry coreceptors for all the alphaherpesviruses
discussed here, whereas others that were identified on
the basis of entry activity for HSV-1 are specific for HSV
strains (Montgomery et al., 1996; Shukla et al., 1999a).
Generate gD Receptors, for Alphaherpesvirus Entry
Mediates entry of
HSV-1
HSV-2 PRV BHV-1WT Rida
Hu-Yesb Hu-No Hu-Yes Hu-No Hu-No
Mu-Yes Mu-Yes Mu-Yes Mu-No Mu-No
Hu-Yes Hu-Yes Hu-Yes Hu-Yes Hu-Yes
Mu-Yes Mu-Yes Mu-Yes Mu-Yes Mu-Yes
Hu-Yes Hu-Yes Hu-Yes Hu-NT Hu-Yes
Hu-No Hu-Yes Hu-Yes Hu-Yes Hu-No
Mu-No Mu-No Mu-No Mu-Yes Mu-No
Hu-No Hu-Yes Hu-NT Hu-NT Hu-NT
Mu-NT Mu-NT Mu-NT Mu-NT Mu-NT
Hu-No Hu-No Hu-No Hu-Yes Hu-Yes
Mu-No Mu-No Mu-No Mu-No Mu-No
Ra-No Ra-No Ra-No Ra-Yes Ra-Yes
Hu-Yes Hu-No Hu-No Hu-No Hu-No
Mu-Yes Mu-No Mu-No Mu-No Mu-No
HSV-1 gD (Rid) and have amino acid substitutions at position 25 or 27
indicated, “Yes” and “No” indicate that the protein has been tested for
not reported.
rthologs of CD155, the poliovirus receptor (B. Baury, D. Masson, P.
paration).ABLE 1
tors, or
d-type
roteins
ted” orThe divergence of gD primary sequences among the
animal and human alphaherpesviruses (Table 2) must
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4 MINIREVIEWpermit conservation of structural features important for
universal binding to nectin-1 while allowing selective
interactions with other gD receptors. The gD receptors
with broad specificity for multiple human and animal
viruses can explain the broad host range of alphaher-
pesviruses, at least with respect to entry. Those with
more limited specificity may explain, at least in part,
biological differences among the various alphaherpesvi-
ruses, including the ability to cause natural disease in
different human or animal hosts. The fact that single
amino acid substitutions in gD can alter receptor prefer-
ences mandates a search for natural gD polymorphisms
that might influence cell tropism and hence pathogene-
sis. The fact that most of the viruses listed in Table 1 use
homologous receptors for entry into mouse and human
cells enhances the utility of mouse models of disease for
studying aspects of pathogenesis dependent on suscep-
tibility of cells to viral entry.
HVEM is expressed in lymphoid cells but also in other
cell types (Kwon et al., 1997; Montgomery et al., 1996).
Mice encode a related protein that is only 45% identical
to the human form (Hsu et al., 1997). Both human and
FIG. 2. Molecular features of wild-type HSV-1 gD and mutant forms
hat have altered receptor preferences. A 25-amino-acid signal peptide
hatched box) is cleaved from the translation product to yield a 369-
mino-acid type 1 membrane protein with its transmembrane domain
cross-hatched box) located near the C-terminus. Three N-linked gly-
ans are located at the positions of the lollipops; the protein also
cquires O-linked glycans. The six Cys residues in the ectodomain are
ovalently linked in the disulfide-bonding pattern indicated by the lines
rawn under the polypeptide chain. These Cys residues are conserved
n all the alphaherpesvirus gDs. Viruses with amino acid substitutions
t position 25 or 27, as indicated, are resistant to interference mediated
y wild-type gD (Rid mutants) resulting from their altered receptor
references. They can enter cells via nectin-2, which is not an effective
ntry receptor for wild-type HSV-1. See review by Cohen et al. (1992) for
citations supporting the structural information summarized here.
T
Amino Acid Sequence Identities in Pai
Origin of
gDa
Number of
amino acidsb HSV-1 gD
HSV-1 394 (100)
HSV-2 393
PRV 400
BHV-1 417
a Strains selected for comparison were HSV-1 (KOS), HSV-2 (333), P
b Lengths of the primary translation products.
c Percent identity determined after alignment by the method of Hein (1990)mouse forms of HVEM can mediate entry of HSV-1 and
HSV-2 strains (except that human HVEM is unable to
mediate entry of HSV-1 Rid mutants) but have no entry
activity for PRV or BHV-1 (Table 1) (Montgomery et al.,
1996; D. Shukla and P. G. Spear, manuscript in prepara-
tion). It remains to be determined whether porcine or
bovine proteins homologous to HVEM might be entry
receptors for the animal viruses.
Natural ligands for HVEM are members of the TNF
family including lymphtoxin-a and LIGHT (Mauri et al.,
998). Both can also serve as ligands for other members
f the TNF receptor family, as diagrammed in Fig. 3. The
ytoplasmic tail of HVEM can transmit signals through
NF receptor-associated factors (TRAFs) resulting, for
xample, in activation of NF-kB and AP-1 (Hsu et al.,
1997; Marsters et al., 1997). LIGHT can stimulate the
proliferation of T cells, presumably through interactions
with HVEM (Harrop et al., 1998; Kwon et al., 1997). LIGHT
can also induce apoptosis of tumor cells expressing both
HVEM and LTbR (Harrop et al., 1998; Zhai et al., 1998),
but the apoptotic activity depends on the LIGHT–LTbR
nteraction (Rooney et al., 2000). Deletion of the cytoplas-
ic tail from HVEM to remove all TRAF-binding se-
uences has no effect on the ability of HVEM to mediate
SV entry (Montgomery et al., 1996). Thus, signal trans-
uction seems not to be required for viral entry, although
ignal transduction might occur when HSV enters a cell
omparisons of Alphaherpesvirus gDs
Percent identityc with
HSV-2 gD PRV gD BHV-1 gD
82.5 25.4 28.4
(100) 25.6 29.3
(100) 38.5
(100)
lan), and BHV-1 (Cooper).
FIG. 3. Four members of the TNF receptor family and their ligands.
Most of the ligands can interact with more than one receptor and
multiple receptors can respond to the same ligand (reviewed by
Wallach et al., 1999).ABLE 2
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5MINIREVIEWvia full-length HVEM and thus influence downstream
events in viral replication or virus–cell interaction.
Nectin-1 and nectin-2 are members of a small subfam-
ily of the immunoglobulin superfamily as described
above. This subfamily also includes CD155, the poliovi-
rus receptor (Mendelsohn et al., 1989), and nectin-3 (Sa-
toh-Horikawa et al., 2000). The human and mouse forms
f nectin-1 have the broadest specificity for mediating
lphaherpesvirus entry (Table 1) and are highly con-
erved in primary sequence (95% identity). It seems likely
hat various mammalian forms of nectin-1 will prove to be
an-alphaherpesvirus entry receptors.
Nectin-2 is more limited in its ability to mediate alpha-
erpesvirus entry (Lopez et al., 2000; Shukla et al., 1999b;
arner et al., 1998). It is of interest that human nectin-2
s a coreceptor for HSV-2 entry but not for most HSV-1
trains unless they have amino acid substitutions at
osition 25 or 27 of gD. It will be important to learn
hether nectin-2, with its specificity for one serotype,
ontributes to differences in the biology of HSV-1 and
SV-2.
It has been difficult to identify rodent homologs of
D155. The most likely candidates are rat and mouse
age4, originally cloned on the basis of their overexpres-
ion in colon cancer (Chadeneau et al., 1994; Chadeneau
t al., 1996). Interestingly, both CD155 and rat Tage4 are
ntry receptors for PRV and BHV-1 but not for HSV
trains (Table 1) (Geraghty et al., 1998; B. Baury, D.
Masson, P. Lustenberger, R. J. Geraghty, P. G. Spear, and
M. G. Denis, manuscript in preparation). To date, only the
mouse version of nectin-3 has been sequenced and it is
not known whether it is an alphaherpesvirus entry re-
ceptor.
Nectin-1, nectin-2, and nectin-3 are homotypic cell
adhesion molecules (Aoki et al., 1997; Lopez et al., 1998;
atoh-Horikawa et al., 2000; Takahashi et al., 1999). Nec-
in-3 can also engage in heterotypic interactions with
ectin-1 and nectin-2 (Satoh-Horikawa et al., 2000). All
embers of this subfamily are expressed, through differ-
ntial splicing of primary transcripts, as multiple iso-
orms that differ in their membrane-spanning and cyto-
lasmic domains or that lack a membrane-spanning do-
ain. Some isoforms of nectin-1, nectin-2, and nectin-3
an localize to cadherin-based adherens junctions in
pithelial cells through binding of their cytoplasmic tails
o PDZ domains in afadin, a cytoplasmic protein that
inds to actin filaments and components of cadherin-
ased cell junctions (Asakura et al., 1999; Mandai et al.,
997; Miyahara et al., 2000; Satoh-Horikawa et al., 2000;
akahashi et al., 1999). This localization is not required
or HSV entry because deletion of the cytoplasmic tail of
ectin-1a is without effect on viral entry (R. J. Geraghty
and P. G. Spear, unpublished results) and an isoform of
nectin-1 that lacks the PDZ-binding cytoplasmic tail has
entry activity (Cocchi et al., 1998). Localization of nectin-1
and nectin-2 to junctions in epithelial cells and ho-
a
bmophilic or heterophilic interactions could very well in-
fluence the availability of receptor for interactions with
virus. Neuronal cells in the nervous system of mice also
express nectin-1 (Shukla et al., 2000; L. Haarr, D. Shukla,
M. Dal Canto, and P. G. Spear, manuscript in prepara-
tion). It will be of interest to determine whether neuronal
nectin-1 is localized to synapses, given the ability of
alphaherpesviruses to be transmitted across synapses
in the nervous system.
Specific sites in heparan sulfate generated by 3-O-
sulfotransferases (3-OSTs) can serve as receptors for gD
and as entry receptors for HSV-1 in the absence of any
known protein receptors (Shukla et al., 1999a). Expres-
sion of mouse or human 3-OST-3A or 3-OST-3B in resis-
ant cells can render the cells susceptible to HSV-1 entry,
ut not to entry of the other viruses discussed here. The
nzymes do not serve as entry receptors themselves but
ather modify heparan sulfate to generate sites for the
inding of gD. The receptors generated by the enzymes
an be removed from cells by the action of heparitinases,
hich render the cells resistant to HSV-1 entry.
Heparan sulfate is constructed by a copolymerase that
dds alternating residues of glucuronic acid and N-
cetylglucosamine to a core oligosaccharide attached to
core protein (Lind et al., 1998; Wei et al., 2000). The
olymer of repeating disaccharides is then modified se-
uentially by several sulfotransferases and an epimer-
se that converts some glucuronic acid residues to idu-
onic acid (reviewed by Lindahl et al., 1998). Multiple
enes encode distinct forms of each sulfotransferase,
hich can differ in substrate specificity. Differential ex-
ression of the various isoforms can lead to distinct
atterns of specific binding sites for proteins, determined
y specific patterns of sulfation and epimerization of
ronic acid residues. One of the final modifications of
eparan sulfate chains is sulfation of the hydroxyl group
FIG. 4. Disaccharides that form part of specific protein binding sites
in heparan sulfate. The site generated by 3-OST-1 is present in a
pentasaccharide that binds antithrombin and the site generated by
3-OST-3 is present in a saccharide of unknown size that binds HSV-1
gD and serves as an entry receptor for HSV.t the 3 position of the amino sugar, a reaction catalyzed
y 3-OSTs. Figure 4 shows specific disaccharides that
r6 MINIREVIEWresult from the action of two different isoforms of 3-OST.
The disaccharide generated by 3-OST-1 is a part of the
specific pentasaccharide that forms the binding site for
antithrombin (Lindahl et al., 1979), whereas the disaccha-
ide generated by 3-OST-3A or 3-OST-3B forms part of the
specific binding site for gD (Liu et al., 1999a,b; Shukla et
al., 1999a). Expression of the latter enzymes, but not of
3-OST-1, generates entry receptors for HSV-1. There are
other isoforms of the 3-OSTs that remain to be tested for
viral entry activity.
Alphaherpesvirus proteins induce membrane fusion
during viral entry into cells and also in the context of
virus-induced cell fusion. The HSV proteins required for
viral entry and for cell–cell fusion are the same, gB, gD,
gH, and gL (reviewed by Spear, 1993b; Turner et al.,
1998). Cell receptors are required for cell–cell fusion
(Terry-Allison et al., 1998, 2000) as well as for viral entry.
The cell fusion receptors identified to date are the gD
receptors for viral entry listed in Table 1. As mentioned
above, gD may not be an essential component of the
membrane-fusing machinery because mutations in the
PRV or BHV-1 genomes can allow infectious virus to be
produced in the absence of gD. However, gD, through its
interaction with a cell surface receptor, apparently pro-
vides the usual trigger for initiating membrane fusion.
One possibility is that the gD-receptor interaction alters
the conformation of gD so that it interacts with gB and/or
gH-gL heterodimers to activate the fusogenic activity of
one or both. The components of the actual membrane-
fusing machinery are not yet known so that any predic-
tions about structural correlates of fusion activity would
be premature.
Given that multiple cell surface receptors can be used
by HSV to enter cells, which ones are actually used by
HSV-1 and HSV-2 to infect epithelial cells at the portal of
entry and to spread to other cells and tissues, including
neuronal cells? Second, are differences in the epidemi-
ology, natural history, or pathogenesis of HSV-1 and
HSV-2 infections explained in part by the fact that mem-
bers of the two serotypes differ somewhat in receptor
preferences (Table 1)?
These questions remain to be answered. Obtaining
the information needed will require a number of ap-
proaches. It is only by culturing cells in vitro that virus
infections can be performed so as to identify the relevant
receptors used for entry. However, the process of disso-
ciating and culturing cells is likely to change the expres-
sion of a variety of genes, including those encoding HSV
receptors or enzymes capable of generating receptors.
Careful comparisons of receptor expression by relevant
cells in situ and after in vitro culture can address this
problem. Recognizing the pitfalls of in vitro studies, pri-
mary cells cultured from the appropriate tissues can be
tested for susceptibility to HSV-1 or HSV-2 infection and
reagents capable of blocking infection via a specific
receptor tested for ability to block infection. For example,primary cultures of human T lymphocytes are suscepti-
ble to HSV-1 infection, which can be substantially inhib-
ited by an antiserum specific for HVEM, indicating that
HVEM is the primary gD receptor used for viral entry
(Montgomery et al., 1996).
In the case of cell types that express multiple HSV-1 or
HSV-2 receptors, one possibility is that any of the recep-
tors could mediate viral entry. Alternatively, in organized
tissues, only one of several expressed receptors may be
accessible for interaction with virus. For example, if the
nectin isoforms expressed are localized to cell junctions
in epithelial cells, they may be unavailable for binding to
incoming virus. Thus, it becomes important to know
which entry receptors are presented on the regions of
the cell surface to which virus can bind.
Because the entry of HSV into human and mouse cells
is largely via homologous receptors, mouse models of
HSV infection can be exploited to provide information
about viral entry. Blocking reagents specific for the var-
ious gD receptors might be used to identify receptors
used by virus for infection of exposed body surfaces
such as the cornea or mucosal epithelium. Mouse mu-
tants deleted for specific genes or unable to express
genes for particular gD receptors in particular cell types
might also prove useful. Finally, it is possible to produce
HSV mutants with altered receptor preferences (Table 1).
Additional mutants of this type might also help to define
the virus–receptor interactions that are important for the
pathogenesis of wild-type virus.
The discovery of multiple HSV receptors belonging to
three classes of cell surface molecules has changed the
way we must think about investigating the requirements
for viral entry into cells and the contribution to viral
pathogenesis of cell susceptibility to entry.
ACKNOWLEDGMENTS
We thank our colleagues who have contributed to the findings from
our own laboratories for their comments and suggestions about this
review. Research done in our laboratories was supported by grants
from the National Institutes of Health, including CA-21776, AI-36293,
and AI-31494 to P.G.S. and AI-18289, NS-30606, NS-36731, and DE-
08239 to G.H.C. and/or R.J.E.
REFERENCES
Aoki, J., Koike, S., Asou, H., Ise, I., Suwa, H., Tanaka, T., Miyasaka, M.,
and Nomoto, A. (1997). Mouse homolog of poliovirus receptor-related
gene 2 product, mPRR2, mediates homophilic cell aggregation. Exp.
Cell Res. 235, 374–384.
Asakura, T., Nakanishi, H., Sakisaka, T., Takahashi, K., Mandai, K.,
Nishimura, M., Sasaki, T., and Takai, Y. (1999). Similar and differential
behaviour between the nectin–afadin–ponsin and cadherin–catenin
systems during the formation and disruption of the polarized junc-
tional alignment in epithelial cells. Genes Cells 4, 573–581.
Banfield, B. W., Leduc, Y., Esford, L., Schubert, K., and Tufaro, F. (1995).
Sequential isolation of proteoglycan synthesis mutants by using
herpes simplex virus as a selective agent: Evidence for a proteogly-
can-independent virus entry pathway. J. Virol. 69, 3290–3298.
Chadeneau, C., LeMoullac, B., and Denis, M. G. (1994). A novel member
7MINIREVIEWof the immunoglobulin gene superfamily expressed in rat carcinoma
cell lines. J. Biol. Chem. 269, 15601–15605.
Chadeneau, C., LeMoullac, B., LeCabellec, M., Mattei, M.-G., Meflah, K.,
and Denis, M. G. (1996). Isolation and chromosomal location of mE4,
a novel murine gene of the immunoglobulin superfamily. Mamm.
Genome 7, 636–637.
Cocchi, F., Menotti, L., Mirandola, P., Lopez, M., and Campadelli-Fiume,
G. (1998). The ectodomain of a novel member of the immunoglobulin
subfamily related to the poliovirus receptor has the attributes of a
bona fide receptor for herpes simplex virus types 1 and 2 in human
cells. J. Virol. 72, 9992–10002.
Cohen, G. H., Muggeridge, M. I., Long, D., Sodora, D. A., and Eisenberg,
R. J. (1992). Structural and functional studies of herpes simplex virus
glycoprotein D. In “Advances in Experimental Medicine and Biology”
(J. E. Ciardi, J. R. McGhee, and J. M. Keith, Eds.), pp. 217–228. Plenum
Press, New York.
Eberle´, F., Dubreuil, P., Mattei, M. G., Devilard, E., and Lopez, M. (1995).
The human PRR2 gene, related to the human poliovirus receptor
gene (PVR), is the true homolog of the murine MPH gene. Gene 159,
267–272.
Geraghty, R. J., Jogger, C. R., and Spear, P. G. (2000). Cellular expression
of alphaherpesvirus gD interferes with entry of homologous and
heterologous alphaherpesviruses by blocking access to a shared gD
receptor. Virology 268, 147–158.
Geraghty, R. J., Krummenacher, C., Cohen, G. H., Eisenberg, R. J., and
Spear, P. G. (1998). Entry of alphaherpesviruses mediated by polio-
virus receptor-related protein 1 and poliovirus receptor. Science 280,
1618–1620.
Gruenheid, S., Gatzke, L., Meadows, H., and Tufaro, F. (1993). Herpes
simplex virus infection and propagation in a mouse L cell mutant
lacking heparan sulfate proteoglycans. J. Virol. 67, 93–100.
Harrop, J. A., McDonnell, P. C., Brigham-Burke, M., Lyn, S. D., Minton, J.,
Tan, K. B., Dede, K., Spampanato, J., Silverman, C., Hensley, P.,
DiPrinzio, R., Emery, J. G., Deen, K., Eichman, C., Chabot-Fletcher, M.,
Truneh, A., and Young, P. R. (1998). Herpesvirus entry mediator ligand
(HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T
cells and inhibits HT29 cell growth. J. Biol. Chem. 273, 27548–27556.
Hein, J. J. (1990). Unified approach to alignment and phylogenies.
Methods Enzymol. 183, 626–645.
Herold, B. C., Visalli, R. J., Susmarski, N., Brandt, C. R., and Spear, P. G.
(1994). Glycoprotein C-independent binding of herpes simplex virus
to cells requires of cell surface heparan sulphate and glycoprotein B.
J. Gen. Virol. 75, 1211–1222.
Herold, B. C., WuDunn, D., Soltys, N., and Spear, P. G. (1991). Glyco-
protein C of herpes simplex virus type 1 plays a principal role in the
adsorption of virus to cells and in infectivity. J. Virol. 65, 1090–1098.
Hsu, H., Solovyev, I., Colombero, A., Elliott, R., Kelley, M., and Boyle, W. J.
(1997). ATAR, a novel tumor necrosis factor receptor family member,
signals through TRAF2 and TRAF5*. J. Biol. Chem. 272, 13471–13474.
Karger, A., Saalmu¨ller, A., Tufaro, F., Banfield, B. W., and Mettenleiter,
T. C. (1995). Cell surface proteoglycans are not essential for infection
by pseudorabies virus. J. Virol. 69, 3482–3489.
Klupp, B. G., Karger, A., and Mettenleiter, T. C. (1997). Bovine herpes-
virus 1 glycoprotein B does not productively interact with cell surface
heparan sulfate in a pseudorabies virion background. J. Virol. 71,
4838–4841.
Krummenacher, C., Nicola, A. V., Whitbeck, J. C., Lou, H., Hou, W.,
Lambris, J. D., Geraghty, R. J., Spear, P. G., Cohen, G. H., and Eisen-
berg, R. J. (1998). Herpes simplex virus glycoprotein D can bind to
poliovirus receptor-related protein 1 or herpes virus entry mediator,
two structurally unrelated mediators of virus entry. J. Virol. 72, 7064–
7074.
Krummenacher, C., Rux, A. H., Whitbeck, J. C., Ponce de Leon, M., Lou,
H., Baribaud, I., Hou, W., Zou, C., Geraghty, R. J., Spear, P. G., Eisen-
berg, R. J., and Cohen, G. H. (1999). The first immunoglobulin-like
domain of HveC is sufficient to bind herpes simplex virus gD with fullaffinity, while the third domain is involved in oligomerization of HveC.
J. Virol. 73, 8127–8137.
Kwon, B. S., Tan, K. B., Ni, J., Oh, K. O., Lee, Z. H., Kim, K. K., Kim, Y. J.,
Wang, S., Gentz, R., Yu, G. L., Harrop, J., Lyn, S. D., Silverman, C.,
Porter, T. G., Truneh, A., and Young, P. R. (1997). A newly identified
member of the tumor necrosis factor receptor superfamily with a
wide tissue distribution and involvement in lymphocyte activation.
J. Biol. Chem. 272, 14272–14276.
Lind, T., Tufaro, F., McCormick, C., and Lindahl, U. (1998). The putative
tumor suppressors EXT1 and EXT2 are glycosyltransferases required
for the biosynthesis of heparan sulfate. J. Biol. Chem. 273, 26265–
26268.
Lindahl, U., Ba¨ckstro¨m, G., Ho¨o¨k, M., Thunberg, L., Fransson, L.-G., and
Linker, A. (1979). Structure of the antithrombin-binding site in heparin.
Proc. Natl. Acad. Sci. USA 76, 3198–3202.
Lindahl, U., Kusche-Gullberg, M., and Kjelle´n, L. (1998). Regulated
diversity of heparan sulfate. J. Biol. Chem. 273, 24979–24982.
Liu, J., Shriver, Z., Blaiklock, P., Yoshida, K., Sasisekharan, R., and
Rosenberg, R. D. (1999a). Heparan sulfate D-glucosaminyl 3-O-sul-
fotransferase 3A sulfates N-unsubstituted glucosamine residues.
J. Biol. Chem. 274, 38155–38162.
Liu, J., Shworak, N. W., Sinay, P., Schwartz, J. J., Zhang, L., Fritze, L. M. S.,
and Rosenberg, R. (1999b). Expression of heparan sulfate D-glu-
cosaminyl 3-O-sulfotransferase isoforms reveals novel substrate
specificities. J. Biol. Chem. 274, 5185–5192.
Lopez, M., Aoubala, M., Jordier, F., Isnardon, D., Gomez, S., and
Dubreuil, P. (1998). The human poliovirus receptor related 2 protein is
a new hematopoietic/endothelial homophilic adhesion molecule.
Blood 92, 4602–4611.
Lopez, M., Cocchi, F., Menotti, L., Avitabile, E., Dubreuil, P., and Cam-
padelli-Fiume, G. (2000). Nectin2a (PRR2a or HveB) and nectin2d are
low-efficiency mediators for entry of herpes simplex virus mutants
carrying the Leu25Pro substitution in glycoprotein D. J. Virol. 74,
1267–1274.
Lopez, M., Eberle´, F., Mattei, M. G., Gabert, J., Birg, F., Bardin, F., Maroc,
C., and Dubreuil, P. (1995). Complementary DNA characterization and
chromosomal localization of a human gene related to the poliovirus
receptor-encoding gene. Gene 155, 261–265.
Mandai, K., Nakanishi, H., Satoh, A., Obaishi, H., Wada, M., Nishioka, H.,
Itoh, M., Mizoguchi, A., Aoki, T., Fujimoto, T., Matsuda, Y., Tsukita, S.,
and Takai, Y. (1997). Afadin: A novel actin filament-binding protein
with one PDZ domain localized at cadherin-based cell–cell adherens
junction. J. Cell Biol. 139, 517–528.
Marsters, S. A., Ayres, T. M., Skubatch, M., Gray, C. L., Rothe, M., and
Ashkenazi, A. (1997). Herpesvirus entry mediator, a member of the
tumor necrosis factor receptor (TNFR) family, interacts with members
of the TNFR-associated factor family and activates the transcription
factors NF-kB and AP-1*. J. Biol. Chem. 272, 14029–14032.
Mauri, D. N., Ebner, R., Montgomery, R. I., Kochel, K. D., Cheung, T. C.,
Yu, G.-L., Ruben, S., Murphy, M., Eisenberg, R. J., Cohen, G. H., Spear,
P. G., and Ware, C. F. (1998). LIGHT, a new member of the TNF
superfamily, and lymphotoxin a are ligands for herpesvirus entry
mediator. Immunity 8, 21–30.
Mendelsohn, C. L., Wimmer, E., and Racaniello, V. R. (1989). Cellular
receptor for poliovirus: Molecular cloning, nucleotide sequence, and
expression of a new member of the immunoglobulin superfamily. Cell
56, 855–865.
Menotti, L., Lopez, M., Avitabile, E., Stefan, A., Cocchi, F., Adelaide, J.,
Lecocq, E., Dubreuil, P., and Campadelli-Fiume, G. (2000). The mu-
rine homolog of human Nectin1d serves as a species nonspecific
mediator for entry of human and animal aherpesviruses in a pathway
independent of a detectable binding to gD. Proc. Natl. Acad. Sci. USA
97, 4867–4872.
Mettenleiter, T. C. (1989). Glycoprotein gIII deletion mutants of pseudo-
rabies virus are impaired in virus entry. Virology 171, 623–625.
Mettenleiter, T. C. (2000). Aujeszky’s disease (pseudorabies) virus: The
MM
S
S
S
S
S
S
S
T
T
T
T
T
W
W
W
W
W
W
Z
8 MINIREVIEWvirus and molecular pathogenesis—State of the art, June 1999. Vet.
Res. 31, 99–115.
Mettenleiter, T. C., Zsak, L., Zuckermann, F., Sugg, N., Kern, H., and
Ben-Porat, T. (1990). Interaction of glycoprotein gIII with a cellular
heparin-like substance mediates adsorption of pseudorabies virus.
J. Virol. 64, 278–286.
iyahara, M., Nakanishi, H., Takahashi, K., Satoh-Horikawa, K., Tachi-
bana, K., and Takai, Y. (2000). Interaction of nectin with afadin is
necessary for its clustering at cell–cell contact sites but not for its cis
dimerization or trans interaction. J. Biol. Chem. 275, 613–618.
ontgomery, R. I., Warner, M. S., Lum, B. J., and Spear, P. G. (1996).
Herpes simplex virus-1 entry into cells mediated by a novel member
of the TNF/NGF receptor family. Cell 87, 427–436.
Nicola, A. V., Ponce de Leon, M., Xu, R., Hou, W., Whitbeck, J. C.,
Krummenacher, C., Montgomery, R. I., Spear, P. G., Eisenberg, R. J.,
and Cohen, G. H. (1998). Monoclonal antibodies to distinct sites on
herpes simplex virus (HSV) glycoprotein D block HSV binding to
HVEM. J. Virol. 72, 3595–3601.
Okazaki, K., Honda, E., Minetoma, T., and Kumagai, T. (1987). Bovine
herpesvirus type 1 gp87 mediates both attachment of virions to
susceptible cells and hemagglutination. Arch. Virol. 97, 297–307.
Okazaki, K., Matsuzaki, T., Sugahara, Y., Okada, J., Hasebe, M.,
Iwamura, Y., Ohnishi, M., Kanno, T., Shimizu, M., and Honda, E. (1991).
BHV-1 adsorption is mediated by the interaction of glycoprotein gIII
with heparin-like moiety on the cell surface. Virology 181, 666–670.
Rooney, I. A., Butrovich, K. D., Glass, A. A., Borboroglu, S., Benedict,
C. A., Whitbeck, J. C., Cohen, G. H., Eisenberg, R. J., and Ware, C. F.
(2000). The lymphotoxin-b receptor is necessary and sufficient for
LIGHT-mediated apoptosis of tumor cells. J. Biol. Chem. 275, 14307–
14315.
Rux, A. H., Willis, S. H., Nicola, A. V., Hou, W., Peng, C., Lou, H., Cohen,
G. H., and Eisenberg, R. J. (1998). Functional region IV of glycoprotein
D from herpes simplex virus modulates glycoprotein binding to the
herpesvirus entry mediator. J. Virol. 72, 7091–7098.
Satoh-Horikawa, K., Nakanishi, H., Takahashi, K., Miyahara, M., Nish-
imura, M., Tachibana, K., Mizoguchi, A., and Takai, Y. (2000). Nectin-3,
a new member of immunoglobulin-like cell adhesion molecules that
shows homophilic and heterophilic cell–cell adhesion activities.
J. Biol. Chem. 275, 10291–10299.
Schmidt, J., Klupp, B. G., Karger, A., and Mettenleiter, T. C. (1997).
Adaptability in herpesviruses: Glycoprotein D-independent infectivity
of pseudorabies virus. J. Virol. 71, 17–24.
Schro¨der, C., Linde, G., Fehler, F., and Keil, G. M. (1997). From essential
to beneficial: Glycoprotein D loses importance for replication of
bovine herpesvirus 1 in cell culture. J. Virol. 71, 25–33.
chro¨der, D., and Keil, G. M. (1999). Bovine herpesvirus 1 requires
glycoprotein H for infectivity and direct spreading and glycoproteins
gHW450 and gB for glycoprotein D-independent cell-to-cell spread.
J. Gen. Virol. 80, 57–61.
hieh, M.-T., WuDunn, D., Montgomery, R. I., Esko, J. D., and Spear, P. G.
(1992). Cell surface receptors for herpes simplex virus are heparan
sulfate proteoglycans. J. Cell Biol. 116, 1273–1281.
hukla, D., Dal Canto, M., Rowe, C. L., and Spear, P. G. (2000). Striking
similarity of murine nectin-1a to human nectin-1a (HveC) in sequence
and activity as a gD receptor for alphaherpesvirus entry. J. Virol., in
press.
hukla, D., Liu, J., Blaiklock, P., Shworak, N. W., Bai, X., Esko, J. D.,
Cohen, G. H., Eisenberg, R. J., Rosenberg, R. D., and Spear, P. G.
(1999a). A novel role for 3-O-sulfated heparan sulfate in herpes
simplex virus 1 entry. Cell 99, 13–22.
hukla, D., Rowe, C. L., Dong, Y., Racaniello, V. R., and Spear, P. G.
(1999b). The murine homolog (Mph) of human herpesvirus entry
protein B (HveB) mediates entry of pseudorabies virus but not herpes
simplex virus types 1 and 2. J. Virol. 73, 4493–4497.pear, P. G. (1993a). Entry of alphaherpesviruses into cells. Semin. Virol.
4, 167–180.
pear, P. G. (1993b). Membrane fusion induced by herpes simplex virus.
In “Viral Fusion Mechanisms” (J. Bentz, Ed.), pp. 201–232. CRC Press,
Boca Raton, FL.
akahashi, K., Nakanishi, H., Miyahara, M., Mandai, K., Satoh, K., Satoh,
A., Nishioka, H., Aoki, J., Nomoto, A., Mizoguchi, A., and Takai, Y.
(1999). Nectin/PRR: An immunoglobulin-like cell adhesion molecule
recruited to cadherin-based adherens junctions through interaction
with afadin, a PDZ domain-containing protein. J. Cell Biol. 145, 539–
549.
erhune, S. S., Coleman, K. T., Sekulovich, R., Burke, R. L., and Spear,
P. G. (1998). Limited variability of glycoprotein gene sequences and
neutralizing targets in herpes simplex virus type 2 isolates and
stability on passage in cell culture. J. Infect. Dis. 178, 8–15.
erry-Allison, T., Montgomery, R. I., Warner, M. S., Geraghty, R. J., and
Spear, P. G. (2000). Contributions of gD receptors and cell surface
glycosaminoglycans to cell fusion mediated by herpes simplex virus
1. Submitted.
erry-Allison, T., Montgomery, R. I., Whitbeck, J. C., Xu, R., Cohen, G. H.,
Eisenberg, R. J., and Spear, P. G. (1998). HveA (herpesvirus entry
mediator A), a coreceptor for herpes simplex virus entry, also partic-
ipates in virus-induced cell fusion. J. Virol. 72, 5802–5810.
urner, A., Bruun, B., Minson, T., and Browne, H. (1998). Glycoproteins
gB, gD and gHgL of herpes simplex virus type 1 are necessary and
sufficient to mediate membrane fusion in a Cos cell transfection
system. J. Virol. 72, 873–875.
allach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko,
A. V., and Boldin, M. P. (1999). Tumor necrosis factor receptor and Fas
signaling mechanisms. Annu. Rev. Immunol. 17, 331–367.
arner, M. S., Geraghty, R. J., Martinez, W. M., Montgomery, R. I.,
Whitbeck, J. C., Xu, R., Eisenberg, R. J., Cohen, G. H., and Spear, P. G.
(1998). A cell surface protein with herpesvirus entry activity (HveB)
confers susceptibility to infection by mutants of herpes simplex virus
type 1, herpes simplex virus type 2, and pseudorabies virus. Virology
246, 179–189.
ei, G., Bai, X., Bame, K. J., Koshy, T. I., Spear, P. G., and Esko, J. D.
(2000). Expression cloning of heparan sulfate copolymerase (EXT1)
and analysis of mutations in Chinese hamster ovary cell mutants
defective in heparan sulfate biosynthesis. J. Biol. Chem., in press.
hitbeck, J. C., Peng, C., Lou, H., Xu, R., Willis, S. H., Ponce de Leon, M.,
Peng, T., Nicola, A. V., Montgomery, R. I., Warner, M. S., Soulika, A. M.,
Spruce, L. A., Moore, W. T., Lambris, J. D., Spear, P. G., Cohen, G. H.,
and Eisenberg, R. J. (1997). Glycoprotein D of herpes simplex virus
(HSV) binds directly to HVEM, a member of the tumor necrosis factor
receptor superfamily and a mediator of HSV entry. J. Virol. 71, 6083–
6093.
illis, S. H., Rux, A. J., Peng, C., Whitbeck, J. C., Nicola, A. V., Lou, H.,
Hou, W., Salvador, L., Eisenberg, R. J., and Cohen, G. H. (1998).
Examination of the kinetics of herpes simplex virus glycoprotein D
binding to the herpesvirus entry mediator, using surface plasmon
resonance. J. Virol. 72, 5937–5947.
uDunn, D., and Spear, P. G. (1989). Initial interaction of herpes simplex
virus with cells is binding to heparan sulfate. J. Virol. 63, 52–58.
hai, Y., Guo, R., Hsu, T.-L., Yu, G.-L., Ni, J., Kwon, B. S., Jiang, G.-W., Lu,
J., Tan, J., Ugustus, M., Carter, K., Rojas, L., Zhu, F., Lincoln, C.,
Endress, G., Xing, L., Wang, S., Oh, K.-O., Gentz, R., Ruben, S.,
Lippman, M. E., Hsieh, S.-L., and Yang, D. (1998). LIGHT, a novel
ligand for lymphotoxin b receptor and TR2/HVEM, induces apoptosis
and suppresses in vivo tumor formation via gene transfer. J. Clin.
Invest. 102, 1142–1151.
